Patents Assigned to Viron Therapeutics
  • Nucleic acid molecules and polypeptides for immune modulation
    Patent number: 6894155
    Abstract: The invention provides gp38 polypeptides, which play a role in immunomodulation, nucleic acid molecules encoding these polypeptides, and therapeutic and diagnostic methods employing these polypeptides and nucleic acid molecules. The invention also provides methods for identifying compounds that modulate the biological activities of gp38 nucleic acid molecules and polypeptides, and therapeutic methods employing these compounds.
    Type: Grant
    Filed: October 11, 2001
    Date of Patent: May 17, 2005
    Assignee: Viron Therapeutics
    Inventors: Grant McFadden, Karim Essani